Literature DB >> 10362131

Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.

M Ohsawa1, S Nakatsuka, H Kanno, H Miwa, S Kojya, Y Harabuchi, W I Yang, K Aozasa.   

Abstract

Nasal lymphoma with polymorphic reticulosis (PR) morphology is now categorized as T/natural killer (T/NK) cell lymphoma. In this study, immunophenotypes and genotypes of proliferating cells in 21 cases with PR were examined. The patients included 13 men and 8 women ranging in age from 20 to 74 (median 37) years. All patients presented with lesions in the upper respiratory tract, mostly in the nasal cavity. Histological specimens obtained from the primary lesions (19 cases) and metastatic cervical lymph nodes (2 cases) were used for analyses. Histologically, polymorphous proliferation was found in 20 cases, and these were thus diagnosed as PR. A monomorphous pattern was found in the remaining last case. Immunohistochemical analysis revealed that the proliferating cells were CD56 (123C3)+ and/or CD16 (2H7)+, TIA-1+ and frequently stained CD3 epsilon+. Tumor cells were frequently stained positively with monoclonal antibodies (mAbs) for T lymphocytes, but were negative for T-cell receptor (TCR) beta and delta chain expression. In situ hybridization analysis using an Epstein-Barr virus-encoded early RNA 1 (EBER-1) probe revealed positive signals in 13 of the 15 cases examined. Southern blotting analysis for clonality of the Epstein-Barr virus (EBV) genome in 12 positive cases confirmed the presence of monoclonal proliferation in 7 cases. The pattern of TCR gamma chain gene rearrangement was examined by PCR analysis of DNA from tumor tissues by the denaturing gradient gel electrophoresis method. The results demonstrated no clonal rearrangement in any of the 21 cases examined, including 7 cases with proven clonal proliferation of EBV-infected cells, indicating the absence of T-cell clones. Our findings strongly suggested that nasal T-cell lymphoma is in fact a NK cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362131     DOI: 10.1002/(sici)1097-0215(19990611)81:6<865::aid-ijc5>3.0.co;2-s

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.

Authors:  Liang Wang; Zhao Wang; Zhong-Jun Xia; Yue Lu; Hui-Qiang Huang; Yu-Jing Zhang
Journal:  Tumour Biol       Date:  2015-05-03

2.  Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior.

Authors:  Mineui Hong; Taehee Lee; So Young Kang; Suk-Jin Kim; Wonseog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-03-25       Impact factor: 7.842

Review 3.  Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.

Authors:  Yasuaki Harabuchi; Miki Takahara; Kan Kishibe; Shigetaka Moriai; Toshihiro Nagato; Hideyuki Ishii
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

4.  Nasal NK/T Cell Lymphoma Presenting with Perforation of Palate: A Case Report and Review of Literature.

Authors:  Shreyas N Shah; Priyank R Mistry; Girish R Chauhan; Vishal Chauhan; Jayshankar Pillai
Journal:  J Clin Diagn Res       Date:  2017-03-01

5.  Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.

Authors:  Tawatchai Pongpruttipan; Tanawan Kummalue; Anan Bedavanija; Archrob Khuhapinant; Koichi Ohshima; Fumiko Arakawa; Daisuke Niino; Sanya Sukpanichnant
Journal:  Diagn Pathol       Date:  2011-08-25       Impact factor: 2.644

Review 6.  Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.

Authors:  Katsuyuki Aozasa; Tetsuya Takakuwa; Tadashi Hongyo; Woo-Ick Yang
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

7.  CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.

Authors:  Jing Yang; Pengfei Li; Yingshi Piao; Xindi Liu; Liqiang Wei; Wei Sang; Luo Zhang; Liang Wang
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

Review 8.  The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.

Authors:  Hyunsung Kim; Young Hyeh Ko
Journal:  Life (Basel)       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.